During the past decade, Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266" are "Branch Retinal Vein Occlusion" (1 trials), "Diabetic Macular Edema" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266" in a lesser frequency.

Most popular intervention types in "Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (2 trials), "Faricimab" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Augenheilkunde 3.B1.266, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".